Back to Search
Start Over
Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy
- Source :
- Thrombosis Research
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
- Subjects :
- 2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19)
Anti-Xa
medicine.medical_treatment
Heparin anti Xa
Anticoagulation management
Letter to the Editors-in-Chief
Extracorporeal Membrane Oxygenation
Coagulopathy
Extracorporeal membrane oxygenation
Humans
Medicine
Acute respiratory distress syndrome (ARDS)
Activated partial thromboplastin time (aPTT)
Retrospective Studies
medicine.diagnostic_test
Heparin
SARS-CoV-2
business.industry
COVID-19
Anticoagulants
Hematology
Extracorporeal membrane oxygenation (ECMO)
medicine.disease
Anesthesia
Partial Thromboplastin Time
business
Partial thromboplastin time
medicine.drug
Subjects
Details
- ISSN :
- 00493848
- Volume :
- 203
- Database :
- OpenAIRE
- Journal :
- Thrombosis Research
- Accession number :
- edsair.doi.dedup.....f77d30b827ab0366f0a0db6beda1404e
- Full Text :
- https://doi.org/10.1016/j.thromres.2021.04.008